Stabilization of solid thyroid drug formulations

Details for Australian Patent Application No. 2001291244 (hide)

Owner Sigmapharm, Inc.

Inventors Spireas, Spiridon

Agent Watermark

Pub. Number AU-B-2001291244

PCT Pub. Number WO02/28364

Priority 09690973 18.10.00 US; 60237442 03.10.00 US

Filing date 26 September 2001

Wipo publication date 15 April 2002

Acceptance publication date 21 September 2006

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/198 (2006.01)

Event Publications

21 September 2006 Application Accepted

  Published as AU-B-2001291244

25 January 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001291245-Fin attachment

2001291243